DZ Bank’s Viking Therapeutics VKTX Stock Holding History

DZ Bank’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,356	Closed	-$256K	–	1038
2024 Q4	$256K	Hold	6,356	–	–	﹤0.01%	790
2024 Q3	$402K	Sell	6,356 -7,150	-53%	-$419K	﹤0.01%	771
2024 Q2	$716K	Buy	+13,506	New	+$885K	﹤0.01%	720

Other funds holding VKTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

DZ Bank's VKTX Position: Q1 2025 in Review

DZ Bank sold out of Viking Therapeutics (VKTX) in Q1 2025, closing a stake of 6,356 shares — an estimated $256K sold.

DZ Bank first reported a position in VKTX in Q2 2024 and held it in 3 quarters. The position peaked at $716K in Q2 2024. 373 funds tracked by Wall St. Rank hold VKTX as of Q1 2025.

DZ Bank reported no remaining Viking Therapeutics position as of Q1 2025 after selling out during the quarter.
DZ Bank sold 6,356 Viking Therapeutics shares in Q1 2025, an estimated $256K.
DZ Bank first reported a position in Viking Therapeutics in Q2 2024 and held it in 3 quarters.
DZ Bank's Viking Therapeutics position peaked at $716K in Q2 2024.
373 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2025.

Based on DZ Bank's 13F filing for Q1 2025, filed 15 May 2025.